Evidence map›Paper›PMID 34907704›Full record

ArticleJournal of applied biomedicine2020

Toxicity assessment of Hypericum olympicum subsp. olympicum L. on human lymphocytes and breast cancer cell lines.

Necmiye Balikci, Mehmet Sarimahmut, Ferda Ari, Nazlihan Aztopal, Mustafa Zafer Ozel, Engin Ulukaya, Serap Celikler

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied biomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Polyprenylated Acylphloroglucinols fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Natural Inhibitors of P-glycoprotein in Acute Myeloid Leukemia.International journal of molecular sciences · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Necmiye BalikciUludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey.
Mehmet SarimahmutUludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey.
Ferda AriUludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey.
Nazlihan AztopalUludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey.
Mustafa Zafer OzelUniversity of York, Department of Chemistry, Heslington, York, United Kingdom.
Engin UlukayaUludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey.
Serap CeliklerUludag University, Faculty of Science and Arts, Department of Biology, Bursa, Turkey.

Funding

Research Fund of Bursa Uludag University BUAP(F)-2014/3Research Fund of Bursa Uludag University OUAP(T)-2015/19
6 · The paper itself

Abstract

There is a limited number of studies about the constituents of Hypericum olympicum subsp. olympicum and its genotoxic and cytotoxic potency. We examined the possible antigenotoxic/genotoxic properties of methanolic extract of H. olympicum subsp. olympicum (HOE) on human lymphocytes by employing sister chromatid exchange, micronucleus and comet assay and analyzed its chemical composition by GCxGC-TOF/MS. The anti-growth activity against MCF-7 and MDA-MB-231 cell lines was assessed by using the ATP viability assay. Cell death mode was investigated with fluorescence staining and ELISA assays. The major components of the flower and trunk were determined as eicosane, heptacosane, 2-propen-1-ol, hexahydrofarnesyl acetone and α-muurolene. HOE caused significant DNA damage at selected doses (250-750 µg/ml) while chromosomal damage was observed at higher concentrations (500 and 750 µg/ml). HOE demonstrated anti-growth activity in a dose-dependent manner between 3.13-100 µg/ml. Pyknotic nuclei were observed at 100 µg/ml concentration of HOE in both cell lines. In conclusion, HOE demonstrated cytotoxic effects in a cell type-dependent manner, however its genotoxic effects were observed at relatively higher doses.

Indexed as

Breast cancerCytotoxicityFolk medicineGenotoxicityHuman lymphocyteHypericum olympicum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.